Fluorescence-Guided Surgery—Illuminating the Limits of Cancer Therapeutics | Synapse
March 3, 2026
Fluorescence-Guided Surgery—Illuminating the Limits of Cancer Therapeutics
Puntos clave
Fluorescence-guided surgery enhances drug delivery understanding in cancer therapy, potentially boosting treatment efficacy.
This method utilizes optically labeled therapeutic antibodies to illuminate tumor margins during surgery.
Observational analysis of drug delivery mechanisms highlights challenges in current cancer therapies and their limitations.
This viewpoint emphasizes the need for further exploration of optical techniques to optimize therapeutic outcomes in oncology.
Resumen
This Viewpoint describes the use of optically labeled therapeutic antibodies in fluorescence-guided surgery to advance understanding of drug delivery in cancer therapy.